Report cover image

Global Pharma Ophthalmic Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 02, 2025
Length 103 Pages
SKU # APRC20103184

Description

Summary

According to APO Research, The global Pharma Ophthalmic market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Pharma Ophthalmic is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Pharma Ophthalmic is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Pharma Ophthalmic is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Pharma Ophthalmic include Akorn, Allergan, Regeneron, Senju, Valeant, Bayer, Santen, Pfizer and Roche, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pharma Ophthalmic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Ophthalmic.

The Pharma Ophthalmic market size, estimations, and forecasts are provided in terms of sales volume (W Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharma Ophthalmic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Pharma Ophthalmic Segment by Company

Akorn
Allergan
Regeneron
Senju
Valeant
Bayer
Santen
Pfizer
Roche
Novartis

Pharma Ophthalmic Segment by Type

Retinal disorders drugs
Glaucoma drugs
Other ophthalmic drugs
Allergic, inflammatory and infective drugs
Dry eye drugs

Pharma Ophthalmic Segment by Application

Dry eye syndrome
Other ophthalmic indications
Glaucoma
Retinal diseases

Pharma Ophthalmic Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Ophthalmic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma Ophthalmic and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Ophthalmic.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharma Ophthalmic manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pharma Ophthalmic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

103 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Pharma Ophthalmic Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Pharma Ophthalmic Sales Estimates and Forecasts (2020-2031)
1.3 Pharma Ophthalmic Market by Type
1.3.1 Retinal disorders drugs
1.3.2 Glaucoma drugs
1.3.3 Other ophthalmic drugs
1.3.4 Allergic, inflammatory and infective drugs
1.3.5 Dry eye drugs
1.4 Global Pharma Ophthalmic Market Size by Type
1.4.1 Global Pharma Ophthalmic Market Size Overview by Type (2020-2031)
1.4.2 Global Pharma Ophthalmic Historic Market Size Review by Type (2020-2025)
1.4.3 Global Pharma Ophthalmic Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Pharma Ophthalmic Sales Breakdown by Type (2020-2025)
1.5.2 Europe Pharma Ophthalmic Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Pharma Ophthalmic Sales Breakdown by Type (2020-2025)
1.5.4 South America Pharma Ophthalmic Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Pharma Ophthalmic Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Pharma Ophthalmic Industry Trends
2.2 Pharma Ophthalmic Industry Drivers
2.3 Pharma Ophthalmic Industry Opportunities and Challenges
2.4 Pharma Ophthalmic Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Pharma Ophthalmic Revenue (2020-2025)
3.2 Global Top Players by Pharma Ophthalmic Sales (2020-2025)
3.3 Global Top Players by Pharma Ophthalmic Price (2020-2025)
3.4 Global Pharma Ophthalmic Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Pharma Ophthalmic Major Company Production Sites & Headquarters
3.6 Global Pharma Ophthalmic Company, Product Type & Application
3.7 Global Pharma Ophthalmic Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Pharma Ophthalmic Market CR5 and HHI
3.8.2 Global Top 5 and 10 Pharma Ophthalmic Players Market Share by Revenue in 2024
3.8.3 2023 Pharma Ophthalmic Tier 1, Tier 2, and Tier 3
4 Pharma Ophthalmic Regional Status and Outlook
4.1 Global Pharma Ophthalmic Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Pharma Ophthalmic Historic Market Size by Region
4.2.1 Global Pharma Ophthalmic Sales in Volume by Region (2020-2025)
4.2.2 Global Pharma Ophthalmic Sales in Value by Region (2020-2025)
4.2.3 Global Pharma Ophthalmic Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Pharma Ophthalmic Forecasted Market Size by Region
4.3.1 Global Pharma Ophthalmic Sales in Volume by Region (2026-2031)
4.3.2 Global Pharma Ophthalmic Sales in Value by Region (2026-2031)
4.3.3 Global Pharma Ophthalmic Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Pharma Ophthalmic by Application
5.1 Pharma Ophthalmic Market by Application
5.1.1 Dry eye syndrome
5.1.2 Other ophthalmic indications
5.1.3 Glaucoma
5.1.4 Retinal diseases
5.2 Global Pharma Ophthalmic Market Size by Application
5.2.1 Global Pharma Ophthalmic Market Size Overview by Application (2020-2031)
5.2.2 Global Pharma Ophthalmic Historic Market Size Review by Application (2020-2025)
5.2.3 Global Pharma Ophthalmic Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Pharma Ophthalmic Sales Breakdown by Application (2020-2025)
5.3.2 Europe Pharma Ophthalmic Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Pharma Ophthalmic Sales Breakdown by Application (2020-2025)
5.3.4 South America Pharma Ophthalmic Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Pharma Ophthalmic Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Akorn
6.1.1 Akorn Comapny Information
6.1.2 Akorn Business Overview
6.1.3 Akorn Pharma Ophthalmic Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Akorn Pharma Ophthalmic Product Portfolio
6.1.5 Akorn Recent Developments
6.2 Allergan
6.2.1 Allergan Comapny Information
6.2.2 Allergan Business Overview
6.2.3 Allergan Pharma Ophthalmic Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Allergan Pharma Ophthalmic Product Portfolio
6.2.5 Allergan Recent Developments
6.3 Regeneron
6.3.1 Regeneron Comapny Information
6.3.2 Regeneron Business Overview
6.3.3 Regeneron Pharma Ophthalmic Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Regeneron Pharma Ophthalmic Product Portfolio
6.3.5 Regeneron Recent Developments
6.4 Senju
6.4.1 Senju Comapny Information
6.4.2 Senju Business Overview
6.4.3 Senju Pharma Ophthalmic Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Senju Pharma Ophthalmic Product Portfolio
6.4.5 Senju Recent Developments
6.5 Valeant
6.5.1 Valeant Comapny Information
6.5.2 Valeant Business Overview
6.5.3 Valeant Pharma Ophthalmic Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Valeant Pharma Ophthalmic Product Portfolio
6.5.5 Valeant Recent Developments
6.6 Bayer
6.6.1 Bayer Comapny Information
6.6.2 Bayer Business Overview
6.6.3 Bayer Pharma Ophthalmic Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bayer Pharma Ophthalmic Product Portfolio
6.6.5 Bayer Recent Developments
6.7 Santen
6.7.1 Santen Comapny Information
6.7.2 Santen Business Overview
6.7.3 Santen Pharma Ophthalmic Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Santen Pharma Ophthalmic Product Portfolio
6.7.5 Santen Recent Developments
6.8 Pfizer
6.8.1 Pfizer Comapny Information
6.8.2 Pfizer Business Overview
6.8.3 Pfizer Pharma Ophthalmic Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pfizer Pharma Ophthalmic Product Portfolio
6.8.5 Pfizer Recent Developments
6.9 Roche
6.9.1 Roche Comapny Information
6.9.2 Roche Business Overview
6.9.3 Roche Pharma Ophthalmic Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Roche Pharma Ophthalmic Product Portfolio
6.9.5 Roche Recent Developments
6.10 Novartis
6.10.1 Novartis Comapny Information
6.10.2 Novartis Business Overview
6.10.3 Novartis Pharma Ophthalmic Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis Pharma Ophthalmic Product Portfolio
6.10.5 Novartis Recent Developments
7 North America by Country
7.1 North America Pharma Ophthalmic Sales by Country
7.1.1 North America Pharma Ophthalmic Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Pharma Ophthalmic Sales by Country (2020-2025)
7.1.3 North America Pharma Ophthalmic Sales Forecast by Country (2026-2031)
7.2 North America Pharma Ophthalmic Market Size by Country
7.2.1 North America Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Pharma Ophthalmic Market Size by Country (2020-2025)
7.2.3 North America Pharma Ophthalmic Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Pharma Ophthalmic Sales by Country
8.1.1 Europe Pharma Ophthalmic Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Pharma Ophthalmic Sales by Country (2020-2025)
8.1.3 Europe Pharma Ophthalmic Sales Forecast by Country (2026-2031)
8.2 Europe Pharma Ophthalmic Market Size by Country
8.2.1 Europe Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Pharma Ophthalmic Market Size by Country (2020-2025)
8.2.3 Europe Pharma Ophthalmic Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Pharma Ophthalmic Sales by Country
9.1.1 Asia-Pacific Pharma Ophthalmic Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Pharma Ophthalmic Sales by Country (2020-2025)
9.1.3 Asia-Pacific Pharma Ophthalmic Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Pharma Ophthalmic Market Size by Country
9.2.1 Asia-Pacific Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Pharma Ophthalmic Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Pharma Ophthalmic Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Pharma Ophthalmic Sales by Country
10.1.1 South America Pharma Ophthalmic Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Pharma Ophthalmic Sales by Country (2020-2025)
10.1.3 South America Pharma Ophthalmic Sales Forecast by Country (2026-2031)
10.2 South America Pharma Ophthalmic Market Size by Country
10.2.1 South America Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Pharma Ophthalmic Market Size by Country (2020-2025)
10.2.3 South America Pharma Ophthalmic Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Pharma Ophthalmic Sales by Country
11.1.1 Middle East and Africa Pharma Ophthalmic Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Pharma Ophthalmic Sales by Country (2020-2025)
11.1.3 Middle East and Africa Pharma Ophthalmic Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Pharma Ophthalmic Market Size by Country
11.2.1 Middle East and Africa Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Pharma Ophthalmic Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Pharma Ophthalmic Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Pharma Ophthalmic Value Chain Analysis
12.1.1 Pharma Ophthalmic Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Pharma Ophthalmic Production Mode & Process
12.2 Pharma Ophthalmic Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Pharma Ophthalmic Distributors
12.2.3 Pharma Ophthalmic Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.